Latest News

New COVID variant on WHO’s radar causing itchy eyes in children


 

A new COVID-19 variant that recently landed on the World Health Organization’s radar may cause previously unseen symptoms in children, according to a new report.

While the variant, called “Arcturus,” hasn’t yet made the Centers for Disease Control and Prevention’s watchlist, a prominent pediatrician in India is seeing children with “itchy” or “sticky” eyes, as if they have conjunctivitis or pinkeye, according to The Times of India.

The new itchy eye symptom is in addition to a high fever and cough, Vipin M. Vashishtha, MD, said on Twitter, noting that pediatric COVID cases have picked up there for the first time in 6 months.

The country has also seen a rise in adenovirus cases among children with similar symptoms. COVID and adenovirus cannot be distinguished without testing, and many parents don’t want to have their children tested because the swabs are uncomfortable, The Times of India reported. One doctor told the newspaper that among every 10 children with COVID-like symptoms, 2 or 3 of them had tested positive on a COVID test taken at home.

Health officials in India are doing mock drills to check how prepared the country’s hospitals are as India sees cases rise, the BBC reported. India struggled during a COVID-19 surge in 2021, at which time sickened people were seen lying on sidewalks outside overflowing hospitals, and reports surfaced of a black market for private citizens to buy oxygen.

Arcturus (formally, Omicron subvariant XBB.1.16) made news recently as it landed on the WHO’s radar after surfacing in India. A WHO official called it “one to watch.” The Times of India reported that 234 new cases of XBB.1.16 were included in the country’s latest 5,676 new infections, meaning the subvariant accounts for 4% of new COVID cases.

A version of this article originally appeared on WebMD.com.

Recommended Reading

COVID-19 potentially induced adult-onset IgA vasculitis
Federal Practitioner
High-dose prophylactic anticoagulation benefits patients with COVID-19 pneumonia
Federal Practitioner
Nasal COVID treatment shows early promise against multiple variants
Federal Practitioner
Negative expectations of COVID shots may amplify side effects
Federal Practitioner
Single bivalent COVID booster is enough for now: CDC
Federal Practitioner
Doctor’s checklist for treating long COVID patients
Federal Practitioner
COVID-19 in pregnancy affects growth in child’s first year of life
Federal Practitioner
SARS-CoV-2 crosses placenta and infects brains of two infants: ‘This is a first’
Federal Practitioner
Long COVID hitting some states, minorities, women harder
Federal Practitioner
Parents of patients with rheumatic disease, MIS-C strongly hesitant of COVID vaccination
Federal Practitioner